Lifesciences Equipment Leasing Market in US 2024-2028

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	162 Pages	TechNavio	March, 2024	INF18655868

Best Price Guarantee
Price	from $2,500
Length	162 Pages
Publisher	TechNavio
Published Date	March, 2024
SKU	INF18655868

Lifesciences Equipment Leasing Market In US 2024-2028

The lifesciences equipment leasing market in US is forecasted to grow by USD 685.99 mn during 2023-2028, accelerating at a CAGR of 7.7% during the forecast period. The report on the lifesciences equipment leasing market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by high cost of life sciences equipment, growing demand from low-budget research institutions, and continuous technological advancements coupled with shorter lifecycles.

Technavio's lifesciences equipment leasing market in US is segmented as below:

By End-user

Pharmaceutical companies
Biopharmaceutical companies

By Product

Chromatography systems
Centrifuges
Mass spectrometry
Incubators
Microscope and others

By Type

Capital lease
Operating lease
Hire purchase

This study identifies the uberization of life sciences equipment leasing as one of the prime reasons driving the lifesciences equipment leasing market in US growth during the next few years. Also, integration of digital platforms by life sciences equipment lessors and rising demand for full leasing of life sciences equipment will lead to sizable demand in the market.

The report on the lifesciences equipment leasing market in US covers the following areas:

Lifesciences equipment leasing market in US sizing
Lifesciences equipment leasing market in US forecast
Lifesciences equipment leasing market in US industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading lifesciences equipment leasing market in US vendors that include Agilent Technologies Inc., American Capital Group Inc., Avtech Financial Group of companies, Commercial Finance and Leasing Cardiff Bank Inc., Crestmont Capital LLC, CSC Leasing Co., Danaher Corp., Excedr Inc., GeNESIS Commercial Capital, GenTech Scientific LLC, Olympus Corp., Peoples Bancorp Inc., Rabobank Group, Royal Bank of Canada, Scientific Equipment Source Inc., Siemens AG, STINSON LLP, Sun South Equipment Leasing Inc., Thermo Fisher Scientific Inc., and Waters Corp.. Also, the lifesciences equipment leasing market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Country Market Characteristics; Exhibit 04: Executive Summary - Chart on Market Segmentation by End-user; Exhibit 05: Executive Summary - Chart on Market Segmentation by Product; Exhibit 06: Executive Summary - Chart on Market Segmentation by Type; Exhibit 07: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 08: Parent market; Exhibit 09: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 10: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 11: Market segments; 3.3 Market size 2023; 3.4 Market outlook: Forecast for 2023-2028; Exhibit 12: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibit 13: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibit 14: Chart on US: Year-over-year growth 2023-2028 (%); Exhibit 15: Data Table on US: Year-over-year growth 2023-2028 (%)
4 Historic Market Size: 4.1 Lifesciences equipment leasing market in US 2018 - 2022; Exhibit 16: Historic Market Size - Data Table on lifesciences equipment leasing market in US 2018 - 2022 ($ million); 4.2 End-user Segment Analysis 2018 - 2022; Exhibit 17: Historic Market Size - End-user Segment 2018 - 2022 ($ million); 4.3 Product Segment Analysis 2018 - 2022; Exhibit 18: Historic Market Size - Product Segment 2018 - 2022 ($ million); 4.4 Type Segment Analysis 2018 - 2022; Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ million)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 20: Five forces analysis - Comparison between 2023 and 2028; 5.2 Bargaining power of buyers; Exhibit 21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; 5.3 Bargaining power of suppliers; Exhibit 22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; 5.4 Threat of new entrants; Exhibit 23: Threat of new entrants - Impact of key factors in 2023 and 2028; 5.5 Threat of substitutes; Exhibit 24: Threat of substitutes - Impact of key factors in 2023 and 2028; 5.6 Threat of rivalry; Exhibit 25: Threat of rivalry - Impact of key factors in 2023 and 2028; 5.7 Market condition; Exhibit 26: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user: 6.1 Market segments; Exhibit 27: Chart on End-user - Market share 2023-2028 (%); Exhibit 28: Data Table on End-user - Market share 2023-2028 (%); 6.2 Comparison by End-user; Exhibit 29: Chart on Comparison by End-user; Exhibit 30: Data Table on Comparison by End-user; 6.3 Pharmaceutical companies - Market size and forecast 2023-2028; Exhibit 31: Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibit 32: Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibit 33: Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibit 34: Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%); 6.4 Biopharmaceutical companies - Market size and forecast 2023-2028; Exhibit 35: Chart on Biopharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibit 36: Data Table on Biopharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibit 37: Chart on Biopharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibit 38: Data Table on Biopharmaceutical companies - Year-over-year growth 2023-2028 (%); 6.5 Market opportunity by End-user; Exhibit 39: Market opportunity by End-user ($ million); Exhibit 40: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Product: 7.1 Market segments; Exhibit 41: Chart on Product - Market share 2023-2028 (%); Exhibit 42: Data Table on Product - Market share 2023-2028 (%); 7.2 Comparison by Product; Exhibit 43: Chart on Comparison by Product; Exhibit 44: Data Table on Comparison by Product; 7.3 Chromatography systems - Market size and forecast 2023-2028; Exhibit 45: Chart on Chromatography systems - Market size and forecast 2023-2028 ($ million); Exhibit 46: Data Table on Chromatography systems - Market size and forecast 2023-2028 ($ million); Exhibit 47: Chart on Chromatography systems - Year-over-year growth 2023-2028 (%); Exhibit 48: Data Table on Chromatography systems - Year-over-year growth 2023-2028 (%); 7.4 Centrifuges - Market size and forecast 2023-2028; Exhibit 49: Chart on Centrifuges - Market size and forecast 2023-2028 ($ million); Exhibit 50: Data Table on Centrifuges - Market size and forecast 2023-2028 ($ million); Exhibit 51: Chart on Centrifuges - Year-over-year growth 2023-2028 (%); Exhibit 52: Data Table on Centrifuges - Year-over-year growth 2023-2028 (%); 7.5 Mass spectrometry - Market size and forecast 2023-2028; Exhibit 53: Chart on Mass spectrometry - Market size and forecast 2023-2028 ($ million); Exhibit 54: Data Table on Mass spectrometry - Market size and forecast 2023-2028 ($ million); Exhibit 55: Chart on Mass spectrometry - Year-over-year growth 2023-2028 (%); Exhibit 56: Data Table on Mass spectrometry - Year-over-year growth 2023-2028 (%); 7.6 Incubators - Market size and forecast 2023-2028; Exhibit 57: Chart on Incubators - Market size and forecast 2023-2028 ($ million); Exhibit 58: Data Table on Incubators - Market size and forecast 2023-2028 ($ million); Exhibit 59: Chart on Incubators - Year-over-year growth 2023-2028 (%); Exhibit 60: Data Table on Incubators - Year-over-year growth 2023-2028 (%); 7.7 Microscope and others - Market size and forecast 2023-2028; Exhibit 61: Chart on Microscope and others - Market size and forecast 2023-2028 ($ million); Exhibit 62: Data Table on Microscope and others - Market size and forecast 2023-2028 ($ million); Exhibit 63: Chart on Microscope and others - Year-over-year growth 2023-2028 (%); Exhibit 64: Data Table on Microscope and others - Year-over-year growth 2023-2028 (%); 7.8 Market opportunity by Product; Exhibit 65: Market opportunity by Product ($ million); Exhibit 66: Data Table on Market opportunity by Product ($ million)
8 Market Segmentation by Type: 8.1 Market segments; Exhibit 67: Chart on Type - Market share 2023-2028 (%); Exhibit 68: Data Table on Type - Market share 2023-2028 (%); 8.2 Comparison by Type; Exhibit 69: Chart on Comparison by Type; Exhibit 70: Data Table on Comparison by Type; 8.3 Capital lease - Market size and forecast 2023-2028; Exhibit 71: Chart on Capital lease - Market size and forecast 2023-2028 ($ million); Exhibit 72: Data Table on Capital lease - Market size and forecast 2023-2028 ($ million); Exhibit 73: Chart on Capital lease - Year-over-year growth 2023-2028 (%); Exhibit 74: Data Table on Capital lease - Year-over-year growth 2023-2028 (%); 8.4 Operating lease - Market size and forecast 2023-2028; Exhibit 75: Chart on Operating lease - Market size and forecast 2023-2028 ($ million); Exhibit 76: Data Table on Operating lease - Market size and forecast 2023-2028 ($ million); Exhibit 77: Chart on Operating lease - Year-over-year growth 2023-2028 (%); Exhibit 78: Data Table on Operating lease - Year-over-year growth 2023-2028 (%); 8.5 Hire purchase - Market size and forecast 2023-2028; Exhibit 79: Chart on Hire purchase - Market size and forecast 2023-2028 ($ million); Exhibit 80: Data Table on Hire purchase - Market size and forecast 2023-2028 ($ million); Exhibit 81: Chart on Hire purchase - Year-over-year growth 2023-2028 (%); Exhibit 82: Data Table on Hire purchase - Year-over-year growth 2023-2028 (%); 8.6 Market opportunity by Type; Exhibit 83: Market opportunity by Type ($ million); Exhibit 84: Data Table on Market opportunity by Type ($ million)
9 Customer Landscape: 9.1 Customer landscape overview; Exhibit 85: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
10 Drivers, Challenges, and Trends: 10.1 Market drivers; 10.2 Market challenges; 10.3 Impact of drivers and challenges; Exhibit 86: Impact of drivers and challenges in 2023 and 2028; 10.4 Market trends
11 Vendor Landscape: 11.1 Overview; 11.2 Vendor landscape; Exhibit 87: Overview on Criticality of inputs and Factors of differentiation; 11.3 Landscape disruption; Exhibit 88: Overview on factors of disruption; 11.4 Industry risks; Exhibit 89: Impact of key risks on business
12 Vendor Analysis: 12.1 Vendors covered; Exhibit 90: Vendors covered; 12.2 Market positioning of vendors; Exhibit 91: Matrix on vendor position and classification; 12.3 Agilent Technologies Inc.; Exhibit 92: Agilent Technologies Inc. - Overview; Exhibit 93: Agilent Technologies Inc. - Business segments; Exhibit 94: Agilent Technologies Inc. - Key news; Exhibit 95: Agilent Technologies Inc. - Key offerings; Exhibit 96: Agilent Technologies Inc. - Segment focus; 12.4 American Capital Group Inc.; Exhibit 97: American Capital Group Inc. - Overview; Exhibit 98: American Capital Group Inc. - Product / Service; Exhibit 99: American Capital Group Inc. - Key offerings; 12.5 Avtech Financial Group of companies; Exhibit 100: Avtech Financial Group of companies - Overview; Exhibit 101: Avtech Financial Group of companies - Product / Service; Exhibit 102: Avtech Financial Group of companies - Key offerings; 12.6 Commercial Finance and Leasing Cardiff Bank Inc.; Exhibit 103: Commercial Finance and Leasing Cardiff Bank Inc. - Overview; Exhibit 104: Commercial Finance and Leasing Cardiff Bank Inc. - Product / Service; Exhibit 105: Commercial Finance and Leasing Cardiff Bank Inc. - Key offerings; 12.7 CSC Leasing Co.; Exhibit 106: CSC Leasing Co. - Overview; Exhibit 107: CSC Leasing Co. - Product / Service; Exhibit 108: CSC Leasing Co. - Key offerings; 12.8 Danaher Corp.; Exhibit 109: Danaher Corp. - Overview; Exhibit 110: Danaher Corp. - Business segments; Exhibit 111: Danaher Corp. - Key news; Exhibit 112: Danaher Corp. - Key offerings; Exhibit 113: Danaher Corp. - Segment focus; 12.9 Excedr Inc.; Exhibit 114: Excedr Inc. - Overview; Exhibit 115: Excedr Inc. - Product / Service; Exhibit 116: Excedr Inc. - Key offerings; 12.10 Olympus Corp.; Exhibit 117: Olympus Corp. - Overview; Exhibit 118: Olympus Corp. - Business segments; Exhibit 119: Olympus Corp. - Key news; Exhibit 120: Olympus Corp. - Key offerings; Exhibit 121: Olympus Corp. - Segment focus; 12.11 Rabobank Group; Exhibit 122: Rabobank Group - Overview; Exhibit 123: Rabobank Group - Business segments; Exhibit 124: Rabobank Group - Key offerings; Exhibit 125: Rabobank Group - Segment focus; 12.12 Royal Bank of Canada; Exhibit 126: Royal Bank of Canada - Overview; Exhibit 127: Royal Bank of Canada - Business segments; Exhibit 128: Royal Bank of Canada - Key offerings; Exhibit 129: Royal Bank of Canada - Segment focus; 12.13 Scientific Equipment Source Inc.; Exhibit 130: Scientific Equipment Source Inc. - Overview; Exhibit 131: Scientific Equipment Source Inc. - Product / Service; Exhibit 132: Scientific Equipment Source Inc. - Key offerings; 12.14 Siemens AG; Exhibit 133: Siemens AG - Overview; Exhibit 134: Siemens AG - Business segments; Exhibit 135: Siemens AG - Key news; Exhibit 136: Siemens AG - Key offerings; Exhibit 137: Siemens AG - Segment focus; 12.15 STINSON LLP; Exhibit 138: STINSON LLP - Overview; Exhibit 139: STINSON LLP - Product / Service; Exhibit 140: STINSON LLP - Key offerings; 12.16 Thermo Fisher Scientific Inc.; Exhibit 141: Thermo Fisher Scientific Inc. - Overview; Exhibit 142: Thermo Fisher Scientific Inc. - Business segments; Exhibit 143: Thermo Fisher Scientific Inc. - Key news; Exhibit 144: Thermo Fisher Scientific Inc. - Key offerings; Exhibit 145: Thermo Fisher Scientific Inc. - Segment focus; 12.17 Waters Corp.; Exhibit 146: Waters Corp. - Overview; Exhibit 147: Waters Corp. - Business segments; Exhibit 148: Waters Corp. - Key news; Exhibit 149: Waters Corp. - Key offerings; Exhibit 150: Waters Corp. - Segment focus
13 Appendix: 13.1 Scope of the report; 13.2 Inclusions and exclusions checklist; Exhibit 151: Inclusions checklist; Exhibit 152: Exclusions checklist; 13.3 Currency conversion rates for US$; Exhibit 153: Currency conversion rates for US$; 13.4 Research methodology; Exhibit 154: Research methodology; Exhibit 155: Validation techniques employed for market sizing; Exhibit 156: Information sources; 13.5 List of abbreviations; Exhibit 157: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by End-user; Exhibits5: Executive Summary - Chart on Market Segmentation by Product; Exhibits6: Executive Summary - Chart on Market Segmentation by Type; Exhibits7: Executive Summary - Chart on Vendor Market Positioning; Exhibits8: Parent market; Exhibits9: Market Characteristics; Exhibits10: Offerings of vendors included in the market definition; Exhibits11: Market segments; Exhibits12: Chart on US - Market size and forecast 2023-2028 ($ million); Exhibits13: Data Table on US - Market size and forecast 2023-2028 ($ million); Exhibits14: Chart on US: Year-over-year growth 2023-2028 (%); Exhibits15: Data Table on US: Year-over-year growth 2023-2028 (%); Exhibits16: Historic Market Size - Data Table on lifesciences equipment leasing market in US 2018 - 2022 ($ million); Exhibits17: Historic Market Size - End-user Segment 2018 - 2022 ($ million); Exhibits18: Historic Market Size - Product Segment 2018 - 2022 ($ million); Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ million); Exhibits20: Five forces analysis - Comparison between 2023 and 2028; Exhibits21: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028; Exhibits22: Bargaining power of suppliers - Impact of key factors in 2023 and 2028; Exhibits23: Threat of new entrants - Impact of key factors in 2023 and 2028; Exhibits24: Threat of substitutes - Impact of key factors in 2023 and 2028; Exhibits25: Threat of rivalry - Impact of key factors in 2023 and 2028; Exhibits26: Chart on Market condition - Five forces 2023 and 2028; Exhibits27: Chart on End-user - Market share 2023-2028 (%); Exhibits28: Data Table on End-user - Market share 2023-2028 (%); Exhibits29: Chart on Comparison by End-user; Exhibits30: Data Table on Comparison by End-user; Exhibits31: Chart on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits32: Data Table on Pharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits33: Chart on Pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits34: Data Table on Pharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits35: Chart on Biopharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits36: Data Table on Biopharmaceutical companies - Market size and forecast 2023-2028 ($ million); Exhibits37: Chart on Biopharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits38: Data Table on Biopharmaceutical companies - Year-over-year growth 2023-2028 (%); Exhibits39: Market opportunity by End-user ($ million); Exhibits40: Data Table on Market opportunity by End-user ($ million); Exhibits41: Chart on Product - Market share 2023-2028 (%); Exhibits42: Data Table on Product - Market share 2023-2028 (%); Exhibits43: Chart on Comparison by Product; Exhibits44: Data Table on Comparison by Product; Exhibits45: Chart on Chromatography systems - Market size and forecast 2023-2028 ($ million); Exhibits46: Data Table on Chromatography systems - Market size and forecast 2023-2028 ($ million); Exhibits47: Chart on Chromatography systems - Year-over-year growth 2023-2028 (%); Exhibits48: Data Table on Chromatography systems - Year-over-year growth 2023-2028 (%); Exhibits49: Chart on Centrifuges - Market size and forecast 2023-2028 ($ million); Exhibits50: Data Table on Centrifuges - Market size and forecast 2023-2028 ($ million); Exhibits51: Chart on Centrifuges - Year-over-year growth 2023-2028 (%); Exhibits52: Data Table on Centrifuges - Year-over-year growth 2023-2028 (%); Exhibits53: Chart on Mass spectrometry - Market size and forecast 2023-2028 ($ million); Exhibits54: Data Table on Mass spectrometry - Market size and forecast 2023-2028 ($ million); Exhibits55: Chart on Mass spectrometry - Year-over-year growth 2023-2028 (%); Exhibits56: Data Table on Mass spectrometry - Year-over-year growth 2023-2028 (%); Exhibits57: Chart on Incubators - Market size and forecast 2023-2028 ($ million); Exhibits58: Data Table on Incubators - Market size and forecast 2023-2028 ($ million); Exhibits59: Chart on Incubators - Year-over-year growth 2023-2028 (%); Exhibits60: Data Table on Incubators - Year-over-year growth 2023-2028 (%); Exhibits61: Chart on Microscope and others - Market size and forecast 2023-2028 ($ million); Exhibits62: Data Table on Microscope and others - Market size and forecast 2023-2028 ($ million); Exhibits63: Chart on Microscope and others - Year-over-year growth 2023-2028 (%); Exhibits64: Data Table on Microscope and others - Year-over-year growth 2023-2028 (%); Exhibits65: Market opportunity by Product ($ million); Exhibits66: Data Table on Market opportunity by Product ($ million); Exhibits67: Chart on Type - Market share 2023-2028 (%); Exhibits68: Data Table on Type - Market share 2023-2028 (%); Exhibits69: Chart on Comparison by Type; Exhibits70: Data Table on Comparison by Type; Exhibits71: Chart on Capital lease - Market size and forecast 2023-2028 ($ million); Exhibits72: Data Table on Capital lease - Market size and forecast 2023-2028 ($ million); Exhibits73: Chart on Capital lease - Year-over-year growth 2023-2028 (%); Exhibits74: Data Table on Capital lease - Year-over-year growth 2023-2028 (%); Exhibits75: Chart on Operating lease - Market size and forecast 2023-2028 ($ million); Exhibits76: Data Table on Operating lease - Market size and forecast 2023-2028 ($ million); Exhibits77: Chart on Operating lease - Year-over-year growth 2023-2028 (%); Exhibits78: Data Table on Operating lease - Year-over-year growth 2023-2028 (%); Exhibits79: Chart on Hire purchase - Market size and forecast 2023-2028 ($ million); Exhibits80: Data Table on Hire purchase - Market size and forecast 2023-2028 ($ million); Exhibits81: Chart on Hire purchase - Year-over-year growth 2023-2028 (%); Exhibits82: Data Table on Hire purchase - Year-over-year growth 2023-2028 (%); Exhibits83: Market opportunity by Type ($ million); Exhibits84: Data Table on Market opportunity by Type ($ million); Exhibits85: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits86: Impact of drivers and challenges in 2023 and 2028; Exhibits87: Overview on Criticality of inputs and Factors of differentiation; Exhibits88: Overview on factors of disruption; Exhibits89: Impact of key risks on business; Exhibits90: Vendors covered; Exhibits91: Matrix on vendor position and classification; Exhibits92: Agilent Technologies Inc. - Overview; Exhibits93: Agilent Technologies Inc. - Business segments; Exhibits94: Agilent Technologies Inc. - Key news; Exhibits95: Agilent Technologies Inc. - Key offerings; Exhibits96: Agilent Technologies Inc. - Segment focus; Exhibits97: American Capital Group Inc. - Overview; Exhibits98: American Capital Group Inc. - Product / Service; Exhibits99: American Capital Group Inc. - Key offerings; Exhibits100: Avtech Financial Group of companies - Overview; Exhibits101: Avtech Financial Group of companies - Product / Service; Exhibits102: Avtech Financial Group of companies - Key offerings; Exhibits103: Commercial Finance and Leasing Cardiff Bank Inc. - Overview; Exhibits104: Commercial Finance and Leasing Cardiff Bank Inc. - Product / Service; Exhibits105: Commercial Finance and Leasing Cardiff Bank Inc. - Key offerings; Exhibits106: CSC Leasing Co. - Overview; Exhibits107: CSC Leasing Co. - Product / Service; Exhibits108: CSC Leasing Co. - Key offerings; Exhibits109: Danaher Corp. - Overview; Exhibits110: Danaher Corp. - Business segments; Exhibits111: Danaher Corp. - Key news; Exhibits112: Danaher Corp. - Key offerings; Exhibits113: Danaher Corp. - Segment focus; Exhibits114: Excedr Inc. - Overview; Exhibits115: Excedr Inc. - Product / Service; Exhibits116: Excedr Inc. - Key offerings; Exhibits117: Olympus Corp. - Overview; Exhibits118: Olympus Corp. - Business segments; Exhibits119: Olympus Corp. - Key news; Exhibits120: Olympus Corp. - Key offerings; Exhibits121: Olympus Corp. - Segment focus; Exhibits122: Rabobank Group - Overview; Exhibits123: Rabobank Group - Business segments; Exhibits124: Rabobank Group - Key offerings; Exhibits125: Rabobank Group - Segment focus; Exhibits126: Royal Bank of Canada - Overview; Exhibits127: Royal Bank of Canada - Business segments; Exhibits128: Royal Bank of Canada - Key offerings; Exhibits129: Royal Bank of Canada - Segment focus; Exhibits130: Scientific Equipment Source Inc. - Overview; Exhibits131: Scientific Equipment Source Inc. - Product / Service; Exhibits132: Scientific Equipment Source Inc. - Key offerings; Exhibits133: Siemens AG - Overview; Exhibits134: Siemens AG - Business segments; Exhibits135: Siemens AG - Key news; Exhibits136: Siemens AG - Key offerings; Exhibits137: Siemens AG - Segment focus; Exhibits138: STINSON LLP - Overview; Exhibits139: STINSON LLP - Product / Service; Exhibits140: STINSON LLP - Key offerings; Exhibits141: Thermo Fisher Scientific Inc. - Overview; Exhibits142: Thermo Fisher Scientific Inc. - Business segments; Exhibits143: Thermo Fisher Scientific Inc. - Key news; Exhibits144: Thermo Fisher Scientific Inc. - Key offerings; Exhibits145: Thermo Fisher Scientific Inc. - Segment focus; Exhibits146: Waters Corp. - Overview; Exhibits147: Waters Corp. - Business segments; Exhibits148: Waters Corp. - Key news; Exhibits149: Waters Corp. - Key offerings; Exhibits150: Waters Corp. - Segment focus; Exhibits151: Inclusions checklist; Exhibits152: Exclusions checklist; Exhibits153: Currency conversion rates for US$; Exhibits154: Research methodology; Exhibits155: Validation techniques employed for market sizing; Exhibits156: Information sources; Exhibits157: List of abbreviations